Can-Fite BioPharma Ltd. (CANF) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Can-Fite BioPharma Ltd.

    AMEX: CANF · Real-Time Price · USD
    0.63
    0.02 (3.26%)
    At close: Sep 26, 2025, 3:59 PM
    0.63
    0.00%
    After-hours: Sep 26, 2025, 03:59 PM EDT

    Can-Fite BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 4.83M 4.28M 2.98M 4.39M
    Short-Term Investments
    		 3.06M 4.64M 5M 14.75M
    Long-Term Investments
    		 n/a n/a 8K n/a
    Other Long-Term Assets
    		 n/a n/a -8K -185K
    Receivables
    		 n/a n/a 47K 48K
    Inventory
    		 n/a n/a -39K -48K
    Other Current Assets
    		 1.09M 78K n/a n/a
    Total Current Assets
    		 8.98M 9.91M 9.16M 20.07M
    Property-Plant & Equipment
    		 138K 81K 126K 185K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 138K 81K 126K 185K
    Total Assets
    		 9.12M 9.99M 9.28M 20.25M
    Account Payables
    		 618K 427K 896K 954K
    Deferred Revenue
    		 405K 622K 783K 818K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 675K 694K 492K 603K
    Total Current Liabilities
    		 2.05M 2.02M 2.5M 2.73M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 1.63M 1.73M 2.31M 3.14M
    Total Liabilities
    		 3.68M 3.75M 4.81M 5.87M
    Total Debt
    		 104K 40K 62K 124K
    Book Value
    		 5.44M 6.24M 4.47M 14.38M
    Book Value Per Share
    		 0.75 1.46 1.64 9.40
    Common Stock
    		 n/a n/a n/a 60.65M
    Retained Earnings
    		 -166.36M -158.48M -150.85M -140.67M
    Comprehensive Income
    		 1.13M 1.13M 1.13M 1.13M
    Shareholders Equity
    		 5.44M 6.24M 4.47M 14.38M
    Total Investments
    		 3.06M 4.64M 5.01M 14.75M

    Add to Watchlist